Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$237B |
3.7x |
8.3x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$190B |
3.0x |
7.7x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€84
|
$127B |
2.4x |
8.2x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 271
|
$96.1B |
6.1x |
18.0x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$95.7B |
2.2x |
6.6x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€192
|
$43.6B |
5.6x |
19.9x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$113
|
$10.9B |
4.1x |
-7.7x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 24
|
$9.5B |
3.5x |
28.0x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 56
|
$9.4B |
N/A |
N/A |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$28
|
$6.5B |
2.7x |
-1.7x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 186
|
$6.5B |
7.0x |
24.7x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2790
|
$5.1B |
11.6x |
36.7x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 73
|
$4.9B |
13.9x |
97.8x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 17
|
$3.9B |
5.9x |
14.9x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 70
|
$3.0B |
17.4x |
-48.1x |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 17
|
$2.9B |
7.2x |
29.9x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 239
|
$2.7B |
2.9x |
8.5x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.7B |
35.7x |
N/A |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$32
|
$2.6B |
N/A |
N/A |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 13
|
$2.5B |
6.3x |
26.3x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8413
|
$2.3B |
N/A |
N/A |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 48100
|
$2.2B |
6.4x |
-91.4x |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 9
|
$1.6B |
44.0x |
-63.4x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 87
|
$1.5B |
7.4x |
19.8x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 15540
|
$1.5B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 25
|
$1.5B |
8.5x |
28.7x |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 19
|
$1.3B |
8.4x |
9.3x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 9
|
$1.2B |
7.1x |
30.0x |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€28
|
$1.2B |
N/A |
N/A |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$10
|
$1.2B |
1.3x |
6.0x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 13
|
$1.2B |
9.7x |
116.4x |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$63
|
$1.1B |
2340.2x |
N/A |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 6
|
$1.1B |
6.1x |
N/A |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$998M |
203.7x |
-4.4x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€5
|
$987M |
4.6x |
-65.6x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$943M |
6.3x |
12.8x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$934M |
3.0x |
41.0x |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 29
|
$931M |
4.0x |
12.8x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$806M |
2.9x |
54.2x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$628M |
79.0x |
-2.6x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 498
|
$612M |
1.7x |
10.1x |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$595M |
N/A |
N/A |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 26
|
$593M |
565.0x |
-30.5x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$18
|
$579M |
225.8x |
-4.5x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$569M |
7.3x |
-22.5x |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 8
|
$540M |
N/A |
-8.7x |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 431
|
$466M |
2.0x |
N/A |
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$442M |
7.0x |
-3.5x |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$435M |
N/A |
N/A |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 40
|
$389M |
19.2x |
-1290.4x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 25
|
$360M |
2.1x |
8.9x |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$333M |
388028.0x |
-13.7x |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$331M |
89.2x |
N/A |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$323M |
658.7x |
N/A |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$10
|
$312M |
1.3x |
-0.9x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$20
|
$309M |
3.0x |
-3.4x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$306M |
955.1x |
N/A |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 23
|
$281M |
1.5x |
6.8x |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 17
|
$278M |
N/A |
N/A |
I-MAB
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$251M |
N/A |
N/A |
Tonix Pharmaceuticals
|
United States of America |
Vaccines & Immunotherapies
|
$40
|
$226M |
20.8x |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$225M |
1.6x |
N/A |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$215M |
2.2x |
-1.6x |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$206M |
N/A |
-5.9x |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$202M |
N/A |
N/A |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$198M |
1.8x |
8.6x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 37
|
$193M |
N/A |
N/A |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$29
|
$188M |
N/A |
N/A |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$185M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$4
|
$167M |
N/A |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€7
|
$162M |
2.4x |
7.3x |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$157M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$155M |
27.6x |
-10.0x |
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$3
|
$147M |
N/A |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$146M |
9.5x |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 16
|
$139M |
N/A |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$138M |
5.4x |
-8.0x |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9320
|
$134M |
N/A |
N/A |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 23
|
$130M |
N/A |
N/A |
Liminatus Pharma
|
United States of America |
Vaccines & Immunotherapies
|
$4
|
$127M |
N/A |
N/A |
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$119M |
3.4x |
-0.2x |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$118M |
N/A |
-1.3x |
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$2
|
$111M |
2.3x |
-0.5x |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$107M |
36585.8x |
-4.3x |
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$93.2M |
N/A |
-3.2x |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$89.0M |
43.9x |
-0.3x |
LakeShore Biopharma Co
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$87.6M |
1.0x |
996.8x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$80.6M |
N/A |
N/A |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$76.0M |
0.6x |
167.6x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$70.8M |
17.8x |
N/A |
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$64.9M |
4.6x |
N/A |
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$64.1M |
484.9x |
N/A |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$15
|
$62.1M |
N/A |
N/A |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$55.7M |
N/A |
-2.6x |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 5
|
$50.8M |
2.8x |
N/A |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$48.6M |
N/A |
N/A |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$48.3M |
786.3x |
N/A |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$48.0M |
3593.2x |
-0.2x |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$44.5M |
N/A |
-1.1x |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$43.1M |
4.9x |
N/A |